EMAIL THIS PAGE TO A FRIEND

Anaerobe

Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.


PMID 25817005

Abstract

Clostridium difficile is well recognized as the common pathogen of nosocomial diarrhea, meanwhile, asymptomatic colonization with C.xa0difficile in part of the population has also drawn public attention. Although gut microbiota is known to play an important role in the pathogenesis of C.xa0difficile infection (CDI), whether there is any alteration of gut microbial composition in asymptomatic C.xa0difficile carriers hasn't been clearly described. The purpose of this study was to explore the differences in gut microbiome among CDI patients, asymptomatic C.xa0difficile carriers and healthy individuals. We performed fecal microbiota analysis on the samples of eight CDI patients, eight asymptomatic C.xa0difficile carriers and nine healthy subjects using 16S rRNA gene pyrosequencing. CDI patients and asymptomatic carriers showed reduced microbial richness and diversity compared with healthy subjects, accompanied with a paucity of phylum Bacteroidetes and Firmicutes as well as an overabundance of Proteobacteria. Some normally commensal bacteria, especially butyrate producers, were significantly depleted in CDI patients and asymptomatic carriers. Furthermore, the differences observed in microbial community structure between CDI patients and asymptomatic carriers suggested that the gut microbiota may be a potential factor of disease state for CDI. Our study demonstrates the characterization and diversity of gut microbiota in CDI and asymptomatic C.xa0difficile colonization, which will provide new ideas for surveillance of the disease state and development of microbiota-targeted agents for CDI prevention and treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C6880
D-Cycloserine, powder
C3H6N2O2
C3909
D-Cycloserine, synthetic
C3H6N2O2
30020
D-Cycloserine, ≥96.0% (NT)
C3H6N2O2